Intrinsic Value of S&P & Nasdaq Contact Us

Adagene Inc. ADAG NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CN • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+31.2%

Stock Statistics — ADAG

Adagene Inc. (ADAG) has a market capitalization of $143.44M and trades at $3.81. The 52-week range is 1.3-4.72.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4, Earnings Per Share (EPS) of $-0.95, annual revenue of $103.2K.

The stock has a beta of 0.71, operates in the Healthcare sector.

Trading Data
Current Price$3.81
52-Week Range1.3-4.72
Volume250.08K
Avg Volume (30D)261.39K
Market Cap$143.44M
Beta (1Y)0.71
Company
IPO Date2021-02-09
Employees138
CEOPeter Luo
CountryCN
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS0053291078
CUSIP005329107
Income (Latest Year)
Revenue$103.2K
Gross Profit$-823.04K
EBITDA$-31.66M
Operating Income$-35.95M
Net Income$-33.42M
EPS$-0.95
EPS Diluted$-0.95
Shares Outstanding$36.02M
Balance Sheet (Latest Year)
Total Assets$89.27M
Current Assets$87.78M
Cash & ST Investments$85.19M
Total Liabilities$38.74M
Total Debt$18.49M
Net Debt$-66.7M
Total Equity$50.52M
Debt / Equity0.37
Valuation Ratios
P/E Ratio-4
P/S Ratio1389.88
P/B Ratio2.84
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message